This podcast is the second in a series of four featuring IBD specialists Drs Anita Afzali, MD, MPH, FACG, AGAF and Nana Bernasko, DNP, CRNP, WHNP-BC. Our moderator for the series is Mr Rick Davis, PA-C. In this episode, our panel of experts review available medication options and their current place in therapy according to recent evidence and guideline recommendations.  Presenters:Anita Afzali, MD, MPH, FACG, AGAFProfessor of Clinical MedicineAbercrombie & Fitch Endowed Chair in Inflammatory Bowel DiseaseMedical Director, OSU Inflammatory Bowel Disease CenterProgram Director, Advanced Inflammatory Bowel Disease FellowshipDivision of Gastroenterology, Hepatology, and NutritionThe Ohio State University Wexner Medical CenterColumbus, OhioNana Bernasko, DNP, CRNP, WHNP-BCAssistant ProfessorDivision of Gastroenterology and Hepatology  Department of MedicinePenn State University Medical CenterHershey, PennsylvaniaRichard H. Davis, PA-CSenior Physician AssistantDivision of Gastroenterology, Hepatology, and NutritionUniversity of Florida College of MedicineGainesville, FloridaThe content in this series was adapted from a live CE program supported by educational grants from Amgen, Ferring Pharmaceuticls, Inc., and the Leona M. and Harry B. Helmsley Charitable Trust.To access the full program, go topce.is/IBD Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios